Page 1 | Search Results | Blood Global Hematology | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Diagnosis and management of multiple myeloma bone disease in Latin America: a GELAMM regional survey

Carolina Romero, Natalia Schutz, Eloisa Riva, Camila Peña

Blood Global Hematology (2026) 2 (1): 100037.

https://doi.org/10.1016/j.bglo.2025.100037

Published: 2026

Includes: Supplemental data

Journal Articles

Infections after CD19 CAR T-cell therapy in a middle-income country: real-world data and review of endemic pathogens

Vanessa dos Anjos Bovolenta, Anita Cassoli Cortez, Ana Costa Cordeiro, Jayr Schmidt-Filho, Marjorie Vieira Batista

Blood Global Hematology (2026) 2 (1): 100046.

https://doi.org/10.1016/j.bglo.2025.100046

Published: 2026

Journal Articles

Hydroxyurea therapy in sickle cell disease: evaluating health care costs and use in a Brazilian tertiary setting

La’Ron L. A. Browne, Emilia Matos do Nascimento, Patricia Moura, Delaine Fidlarczyk, Jane Duran, Roberto Barbosa, Thais Oliveira, George Goshua, Jane S. Hankins, Clarisse Lobo

Blood Global Hematology (2026) 2 (1): 100040.

https://doi.org/10.1016/j.bglo.2025.100040

Published: 2026

Includes: Supplemental data

Journal Articles

CNS prophylaxis in patients with DLBCL: Lymphoma Subcommittee of the Argentinian Society of Hematology experience

Blood Global Hematology (2026) 2 (1): 100047.

https://doi.org/10.1016/j.bglo.2025.100047

Published: 2026

Journal Articles

Gap in hematologic cancer burden analysis across South Asia

Sejong Bae

Blood Global Hematology (2026) 2 (1): 100038.

https://doi.org/10.1016/j.bglo.2025.100038

Published: 2026

Journal Articles

Tracing the origin of sickle cell disease back to 50 000 years

Dinesh Pendharkar, Garima Nirmal

Blood Global Hematology (2026) 2 (1): 100041.

https://doi.org/10.1016/j.bglo.2025.100041

Published: 2026

Journal Articles

Implementation of a public policy in inherited bleeding disorders in a less-resourced country: the Brazilian experience

Suely M. Rezende, Erich V. De Paula

Blood Global Hematology (2026) 2 (1): 100052.

https://doi.org/10.1016/j.bglo.2025.100052

Published: 2026

Journal Articles

Hematologic cancers in the SAARC region: current burden in 2022 and projections to 2050

Alessandro Hammond, Sruthi Ranganathan, Urvish Jain, Bhav Jain, Puneeth Iyengar, Erin Jay G. Feliciano, Nishwant Swami, James Fan Wu, Bishal Gyawali, Aju Mathew, C. S. Pramesh, Edward Christopher Dee, Freddie Bray, Manju Sengar

Blood Global Hematology (2026) 2 (1): 100036.

https://doi.org/10.1016/j.bglo.2025.100036

Published: 2026

Includes: Supplemental data

Journal Articles

The rare lifeline: struggle and strategy behind O h (Bombay) blood group transfusions

Aditi Khanna, Bhagyashri Surve, Suryatapa Saha, Shashank Ojha, Chitra Dewanji, Surangma Singh

Blood Global Hematology (2026) 2 (1): 100044.

https://doi.org/10.1016/j.bglo.2025.100044

Published: 2026

Journal Articles

Outpatient low-dose venetoclax-azacitidine vs intensive therapy in newly diagnosed AML in resource-limited settings

Fernando De la Garza-Salazar, Yadith Karina Lopez-Garcia, Alexis De la Rosa-Flores, Paulo Ugarte-Peláez, Juan Carlos Olivares-Gazca, Guillermo Ruiz-Argüelles, David Gómez-Almaguer, Andrés Gómez-De León

Blood Global Hematology (2026) 2 (1): 100045.

https://doi.org/10.1016/j.bglo.2025.100045

Published: 2026

Includes: Supplemental data

Journal Articles

CAR-T in resource-limited regions

Diego V. Clé, Camila D. Donadel, Rodrigo T. Calado

Blood Global Hematology (2026) 2 (1): 100051.

https://doi.org/10.1016/j.bglo.2025.100051

Published: 2026

Includes: Supplemental data

Journal Articles

Bridging the gap: AML induction in low-resource settings

Jennifer R. Croden, Courtney D. DiNardo

Blood Global Hematology (2026) 2 (1): 100049.

https://doi.org/10.1016/j.bglo.2025.100049

Published: 2026

Journal Articles

Urinary carbonic anhydrase 1 excretion is a marker of hemolysis-triggering conditions suitable for point-of-care testing

Blood Global Hematology 100058.

https://doi.org/10.1016/j.bglo.2025.100058

Published: 2025

Journal Articles

Intensive induction for older AML patients in resource-constrained setting: insights from a Brazilian multicenter cohort

Frederico Lisboa Nogueira, Fernanda Rodrigues Mendes, Wellington Fernandes da Silva, Raphael Costa Bandeira de Melo, Camila Dermínio Donadel, Maria Isabel Ayrosa Madeira, Lorena Lôbo de Figueiredo Pontes, Robert Eduardo Emídio, Sandra Guerra Xavier, Ana Beatriz Firmato Glória, Evandro Maranhão Fagundes, Eduardo Magalhães Rego

Blood Global Hematology 100057.

https://doi.org/10.1016/j.bglo.2025.100057

Published: 2025

Includes: Supplemental data

Journal Articles

Hemoglobin A2 Levels in Indian Patients with Sickle Cell Disease Reveal Heterozygosity

Dinesh Pendharkar, Garima Nirmal

Blood Global Hematology 100059.

https://doi.org/10.1016/j.bglo.2025.100059

Published: 2025

Journal Articles

Poor outcomes of NPM1-mutated AML in Brazil despite traditional risks and recent adoption of molecular monitoring

Maria Victória Azevedo, Fernanda Mendes, Raphael de Melo, Luciana Nardinelli, Israel Bendit, Elvira Velloso, Vanderson Rocha, Eduardo Rego, Wellington Silva

Blood Global Hematology 100055.

https://doi.org/10.1016/j.bglo.2025.100055

Published: 2025

Includes: Supplemental data

Journal Articles

Clinical outcomes of patients with chronic myeloid leukemia with asciminib provided by a compassionate program in Brazil

Blood Global Hematology (2025) 1 (3): 100035.

https://doi.org/10.1016/j.bglo.2025.100035

Published: 2025

Journal Articles

Baseline characteristics, treatment, and outcomes of indolent lymphoma in Malawi: a prospective, observational cohort

Tarsizious Chikaonda, Marriam Mponda, Bongani Kaimila, Edwards Kasonkanji, Maria Chikasema, Lusayo Simwinga, Noel Mumba, Richard Nyasosela, Maurice Mulenga, Tamiwe Tomoka, Satish Gopal, Yuri Fedoriw, Matthew S Painschab

Blood Global Hematology 100050.

https://doi.org/10.1016/j.bglo.2025.100050

Published: 2025

Journal Articles

Real-world outcome of acute promyelocytic leukemia treatment in a resource-constrained setting: an experience from Nepal

Bishesh Sharma Poudyal, Rukmani Shahi, Bishal Poudel, Tanbir Ikram, Suman Gaire, Utsav Joshi

Blood Global Hematology (2025) 1 (3): 100030.

https://doi.org/10.1016/j.bglo.2025.100030

Published: 2025

Journal Articles

From donor to diagnosis: using blood banks to estimate MGUS prevalence in a Mexican population

Carlos de la Cruz-de la Cruz, Jorge Alberto Zamayoa Torres, Odra Martínez González, Nefertiti Castro Fuentes, Andrés Gómez-de León, David Gómez-Almaguer, Luz Tarín-Arzaga

Blood Global Hematology (2025) 1 (3): 100034.

https://doi.org/10.1016/j.bglo.2025.100034

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Diagnosis and management of multiple myeloma bone disease in Latin America: a GELAMM regional survey

Infections after CD19 CAR T-cell therapy in a middle-income country: real-world data and review of endemic pathogens

Hydroxyurea therapy in sickle cell disease: evaluating health care costs and use in a Brazilian tertiary setting

CNS prophylaxis in patients with DLBCL: Lymphoma Subcommittee of the Argentinian Society of Hematology experience

Gap in hematologic cancer burden analysis across South Asia

Tracing the origin of sickle cell disease back to 50 000 years

Implementation of a public policy in inherited bleeding disorders in a less-resourced country: the Brazilian experience

Hematologic cancers in the SAARC region: current burden in 2022 and projections to 2050

The rare lifeline: struggle and strategy behind O h (Bombay) blood group transfusions

Outpatient low-dose venetoclax-azacitidine vs intensive therapy in newly diagnosed AML in resource-limited settings

CAR-T in resource-limited regions

Bridging the gap: AML induction in low-resource settings

Urinary carbonic anhydrase 1 excretion is a marker of hemolysis-triggering conditions suitable for point-of-care testing

Intensive induction for older AML patients in resource-constrained setting: insights from a Brazilian multicenter cohort

Hemoglobin A2 Levels in Indian Patients with Sickle Cell Disease Reveal Heterozygosity

Poor outcomes of NPM1-mutated AML in Brazil despite traditional risks and recent adoption of molecular monitoring

Clinical outcomes of patients with chronic myeloid leukemia with asciminib provided by a compassionate program in Brazil

Baseline characteristics, treatment, and outcomes of indolent lymphoma in Malawi: a prospective, observational cohort

Real-world outcome of acute promyelocytic leukemia treatment in a resource-constrained setting: an experience from Nepal

From donor to diagnosis: using blood banks to estimate MGUS prevalence in a Mexican population

ASH Publications

American Society of Hematology

Update search

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only